
Regeneron Pharmaceuticals Inc (REGN34)
BOV
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 15.231 | 23.849 | 15.944 | 21.979 | 37.914 | 15.877 | 12.693 | 12.458 |
Return on Equity (%) | 22.628 | 32.808 | 21.321 | 31.772 | 54.207 | 20.942 | 16.258 | 15.951 |
Return on Invested Capital (%) | 30.494 | 42.064 | 26.677 | 38.453 | 69.274 | 28.802 | 20.938 | 19.159 |
Operating Margin (%) | 35.823 | 38.471 | 31.275 | 45.513 | 58.383 | 40.403 | 32.57 | 34.045 |
Net Profit Margin (%) | 20.41 | 36.425 | 26.907 | 41.346 | 50.245 | 35.64 | 30.141 | 31.07 |
Book Value Per Share | 27.292 | 38.352 | 49.752 | 50.984 | 85.431 | 98.167 | 113.215 | 126.977 |
Earnings Per Share | 5.324 | 10.705 | 9.492 | 16.246 | 36.757 | 19.582 | 17.951 | 19.865 |
Cash Per Share | 3.61 | 6.428 | 7.258 | 10.144 | 13.135 | 14.019 | 12.396 | 11.202 |
Working Capital Per Share | 14.212 | 21.918 | 25.09 | 32.748 | 45.893 | 57.517 | 72.901 | 66.253 |
Operating Profit Per Share | 24.952 | 28.12 | 32.689 | 36.478 | 63.547 | 49.849 | 53.235 | 57.24 |
EBIT Per Share | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 | 21.519 |
EBITDA Per Share | 9.233 | 11.183 | 10.898 | 17.62 | 42.449 | 21.931 | 19.067 | 21.519 |
Free Cash Flow Per Share | 5.903 | 11.752 | 10.499 | 18.021 | 37.989 | 25.339 | 20.246 | 21.66 |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 109.48M | 111.09M | 108.43M | 105.1M | 106.85M | 107.8M | N/A | N/A |
Year End December 30 2024 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | 27.703 | N/A | N/A | N/A | 22.792 | N/A | N/A | N/A |
Net Profit Margin (%) | 25.863 | N/A | N/A | N/A | 22.957 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 7.16B |
Price to Earnings Ratio | 17.15 |
Price to Sales Ratio | 5.33 |
Price to Cash Ratio | 30.42 |
Price to Book Ratio | 2.58 |
Dividend Yield | - |
Shares Outstanding | 108.07M |
Average Volume (1 week) | 32 |
Average Volume (1 Month) | 579 |
52 Week Change | -15.89% |
52 Week High | 111.72 |
52 Week Low | 60.11 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.